Xylem Financial Statements (XYL)
|
|
Report date
|
|
|
25.02.2022 |
31.12.2022 |
24.02.2023 |
31.12.2023 |
28.02.2024 |
|
31.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
5 195 |
5 522 |
5 522 |
7 364 |
7 364 |
|
8 424 |
Operating Income, bln rub |
|
|
585.0 |
622.0 |
622.0 |
728.0 |
652.0 |
|
1 008 |
EBITDA, bln rub |
? |
|
853.0 |
601.0 |
755.0 |
1 164 |
1 288 |
|
1 635 |
Net profit, bln rub |
? |
|
427.0 |
355.0 |
355.0 |
609.0 |
609.0 |
|
830.0 |
|
OCF, bln rub |
? |
|
538.0 |
596.0 |
596.0 |
837.0 |
837.0 |
|
1 143 |
CAPEX, bln rub |
? |
|
208.0 |
208.0 |
208.0 |
271.0 |
271.0 |
|
315.0 |
FCF, bln rub |
? |
|
330.0 |
388.0 |
388.0 |
566.0 |
566.0 |
|
828.0 |
Dividend payout, bln rub
|
|
|
203.0 |
217.0 |
217.0 |
299.0 |
299.0 |
|
343.0 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
47.5% |
61.1% |
61.1% |
49.1% |
49.1% |
|
41.3% |
|
OPEX, bln rub |
|
|
1 383 |
1 433 |
1 433 |
1 989 |
2 065 |
|
1 819 |
Cost of production, bln rub |
|
|
3 220 |
3 438 |
3 438 |
4 647 |
4 647 |
|
5 310 |
R&D, bln rub |
|
|
204.0 |
206.0 |
206.0 |
232.0 |
232.0 |
|
232.0 |
Interest expenses, bln rub |
|
|
76.0 |
50.0 |
50.0 |
49.0 |
49.0 |
|
56.0 |
|
Assets, bln rub |
|
|
8 276 |
7 952 |
7 952 |
16 112 |
16 112 |
|
16 046 |
Net Assets, bln rub |
? |
|
3 218 |
3 494 |
3 494 |
10 166 |
10 166 |
|
10 593 |
Debt, bln rub |
|
|
2 440 |
1 880 |
1 949 |
2 284 |
2 662 |
|
2 103 |
Cash, bln rub |
|
|
1 349 |
944.0 |
944.0 |
1 019 |
1 019 |
|
989.0 |
Net debt, bln rub |
|
|
1 091 |
936.0 |
1 005 |
1 265 |
1 643 |
|
1 114 |
|
Ordinary share price, rub |
|
|
119.9 |
110.6 |
110.6 |
114.4 |
114.4 |
|
94.3 |
Number of ordinary shares, mln |
|
|
180.2 |
180.2 |
180.2 |
218.2 |
217.0 |
|
242.9 |
|
Market cap, bln rub |
|
|
21 615 |
19 925 |
19 927 |
24 953 |
24 814 |
|
22 906 |
EV, bln rub |
? |
|
22 706 |
20 861 |
20 932 |
26 218 |
26 457 |
|
24 020 |
Book value, bln rub |
|
|
-590 |
-155 |
-155 |
2 579 |
50 |
|
674 |
|
EPS, rub |
? |
|
2.37 |
1.97 |
1.97 |
2.79 |
2.81 |
|
3.42 |
FCF/share, rub |
|
|
1.83 |
2.15 |
2.15 |
2.59 |
2.61 |
|
3.41 |
BV/share, rub |
|
|
-3.27 |
-0.86 |
-0.86 |
11.8 |
0.23 |
|
2.77 |
|
EBITDA margin, % |
? |
|
16.4% |
10.9% |
13.7% |
15.8% |
17.5% |
|
19.4% |
Net margin, % |
? |
|
8.22% |
6.43% |
6.43% |
8.27% |
8.27% |
|
9.85% |
FCF yield, % |
? |
|
1.53% |
1.95% |
1.95% |
2.27% |
2.28% |
|
3.61% |
ROE, % |
? |
|
13.3% |
10.2% |
10.2% |
5.99% |
5.99% |
|
7.84% |
ROA, % |
? |
|
5.16% |
4.46% |
4.46% |
3.78% |
3.78% |
|
5.17% |
|
P/E |
? |
|
50.6 |
56.1 |
56.1 |
41.0 |
40.7 |
|
27.6 |
P/FCF |
|
|
65.5 |
51.4 |
51.4 |
44.1 |
43.8 |
|
27.7 |
P/S |
? |
|
4.16 |
3.61 |
3.61 |
3.39 |
3.37 |
|
2.72 |
P/BV |
? |
|
-36.6 |
-128.5 |
-128.6 |
9.68 |
496.3 |
|
34.0 |
EV/EBITDA |
? |
|
26.6 |
34.7 |
27.7 |
22.5 |
20.5 |
|
14.7 |
Debt/EBITDA |
|
|
1.28 |
1.56 |
1.33 |
1.09 |
1.28 |
|
0.68 |
|
R&D/CAPEX, % |
|
|
98.1% |
99.0% |
99.0% |
85.6% |
85.6% |
|
73.7% |
|
CAPEX/Revenue, % |
|
|
4.00% |
3.77% |
3.77% |
3.68% |
3.68% |
|
3.74% |
|
Xylem shareholders |